Clinical Trial Update: Alpha-type-1 Dendritic Cell-based Vaccines in Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Alpha-type-1 Dendritic Cell-based Vaccines in patients with metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Alpha-type-1 Dendritic Cell-based Vaccines

Snippet

Sponsor: Pawel Kalinski | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED